Anzeige
Erschienen in:
01.12.2023 | News item
Non-serious case reports
Erschienen in: Reactions Weekly | Ausgabe 1/2023
Einloggen, um Zugang zu erhaltenExcerpt
The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week.|
Non-serious case reports
|
||
|---|---|---|
|
Drug name(s)
|
Adverse event(s)
|
No. of cases
|
|
Adenosine
|
Signs symptoms and ill defined conditions
|
1
|
|
Alirocumab
|
Blister, Skin disorders
|
1
|
|
Amoxicillin/clavulanic acid, Cefalexin
|
Exanthema, Respiratory signs and symptoms
|
2
|
|
Asciminib
|
Pleural effusion
|
1
|
|
Avelumab
|
Psoriasis
|
1
|
|
AZD 1222, BBV 152
|
Injection site pain, Pregnancy, Vomiting
|
2
|
|
AZD 1222, Elasomeran, Tozinameran
|
Immunological disorders
|
22
|
|
Baricitinib
|
Conjunctivitis
|
1
|
|
BCG vaccine
|
Keloids
|
1
|
|
Bevacizumab, Oxaliplatin, Raltitrexed, Sintilimab
|
Fatigue, Nausea, Stomatitis
|
1
|
|
Botulinum Toxin A
|
Deglutition disorders
|
1
|
|
Cannabidiol
|
Abnormal laboratory parameters
|
1
|
|
Cannabidiol, Nabiximols
|
Confusion, Diarrhoea, Euphoria, Neurological disorders, Paranoid disorders, Vomiting
|
7
|
|
Cefdinir, Iron, Multivitamin
|
3
|
|
|
Cetearyl glucoside/glycerol/phosphatidylcholine/silver oxide, Selenium, Silver oxide
|
Argyria
|
1
|
|
Cetuximab
|
Acneiform eruptions, Dry eyes, Dyspnoea, Exanthema, Fatigue
|
13
|
|
Citalopram
|
Anxiety, Cognition disorders, Mood disorders, Somnolence
|
1
|
|
Collagenase clostridium histolyticum
|
Injection site reactions
|
3
|
|
Cyanoacrylate
|
Delayed hypersensitivity
|
1
|
|
Cyclophosphamide, Doxorubicin, Osimertinib
|
Fatigue
|
1
|
|
Daratumumab
|
Erythema, Fever, Muscular disorders, Nausea and vomiting
|
1
|
|
Doxycycline
|
Exanthema
|
1
|
|
Erlotinib
|
Acneiform eruptions
|
2
|
|
Esketamine
|
Nausea, Vomiting
|
1
|
|
Ethiodized oil, Fluorouracil, Lenvatinib, Pirarubicin
|
Signs symptoms and ill defined conditions
|
1
|
|
Gabapentin
|
Weight gain
|
1
|
|
Gemcitabine, Gimeracil/oteracil/tegafur
|
Exanthema
|
1
|
|
Hepatitis B vaccine recombinant, Hib DTaP hepatitis B poliovirus vaccine, Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa), Hib DTaP poliovirus vaccine, Meningococcal vaccine group B OMV Novartis, Pneumococcal 13 valent CRM197 vaccine conjugate
|
Granuloma
|
1
|
|
Hydroquinone
|
Allergic contact dermatitis
|
1
|
|
Hydroxychloroquine, Leflunomide, Methotrexate
|
Exanthema, Nausea and vomiting
|
2
|
|
Insulin glargine/lixisenatide
|
Nausea
|
1
|
|
Interleukin 2
|
Induration, Injection site reactions
|
1
|
|
Isotretinoin
|
Dry eyes, Skin disorders
|
1
|
|
Lenalidomide, Rituximab, Tucidinostat
|
Nausea
|
1
|
|
Lenvatinib
|
Arthralgia, Fatigue, Muscle pain, Tendon injuries
|
1
|
|
Leuprorelin
|
Alopecia, Vasomotor symptoms
|
1
|
|
Levetiracetam
|
Erythema, Oedema
|
1
|
|
Methotrexate
|
Signs symptoms and ill defined conditions
|
1
|
|
Minocycline
|
Nail disorders, Pigmentation, Skin pigmentation
|
1
|
|
Minoxidil
|
Chest pain, Skin disorders
|
1
|
|
Nintedanib
|
Nausea, Vomiting
|
1
|
|
Nirmatrelvir+ritonavir
|
Dysgeusia
|
1
|
|
Obinutuzumab, Rituximab
|
Headache, Vomiting
|
1
|
|
Risdiplam
|
Photosensitivity
|
6
|
|
Rocuronium bromide, Suxamethonium chloride
|
Neuromuscular disorders
|
1
|
|
Ropeginterferon alfa 2b
|
Injection site reactions
|
1
|
|
Tozinameran
|
Abnormal laboratory parameters
|
1
|
|
Triamcinolone
|
Injection site reactions, Skin atrophy
|
1
|
|
Vancomycin
|
Abnormal laboratory parameters, Drug eruptions
|
1
|